Form 8-K - Current report:
SEC Accession No. 0001437749-19-023451
Filing Date
2019-11-22
Accepted
2019-11-22 16:04:50
Documents
5
Period of Report
2019-11-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20191121_8k.htm 8-K 35906
2 EXHIBIT 5.1 ex_165660.htm EX-5.1 18619
3 EXHIBIT 10.1 ex_165667.htm EX-10.1 227994
4 EXHIBIT 10.2 ex_165668.htm EX-10.2 98949
5 logo1.jpg GRAPHIC 9180
  Complete submission text file 0001437749-19-023451.txt   395287
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 191241526
SIC: 2834 Pharmaceutical Preparations